Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Morel

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2004
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptorDamien Derouet, François Rousseau, Fabienne Alfonsi, et al.
The Journal of Biological Chemistry|September 25, 2003
GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptorCaroline Diveu, Eric Lelièvre, David Perret, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2016
Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancerYann Touchefeu, Marie Provost-Dewitte, Thierry Lecomte, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2011
A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerDamien Besson, Aude-Hélène Pavageau, Isabelle Valo, et al.
Journal of Hepatology|December 24, 2021
IL-26 inhibits hepatitis C virus replication in hepatocytesÉlodie Beaumont, Vincent Larochette, Laurence Preisser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2017
IL-26 Confers Proinflammatory Properties to Extracellular DNACaroline Poli, Jean François Augusto, Jonathan Dauvé, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Seminars in Oncology|April 12, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approachMichele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
Seminars in Oncology|September 20, 2017
In replyMichele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2004
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptorDamien Derouet, François Rousseau, Fabienne Alfonsi, et al.
The Journal of Biological Chemistry|September 25, 2003
GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptorCaroline Diveu, Eric Lelièvre, David Perret, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2016
Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancerYann Touchefeu, Marie Provost-Dewitte, Thierry Lecomte, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2011
A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerDamien Besson, Aude-Hélène Pavageau, Isabelle Valo, et al.
Journal of Hepatology|December 24, 2021
IL-26 inhibits hepatitis C virus replication in hepatocytesÉlodie Beaumont, Vincent Larochette, Laurence Preisser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2017
IL-26 Confers Proinflammatory Properties to Extracellular DNACaroline Poli, Jean François Augusto, Jonathan Dauvé, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Seminars in Oncology|April 12, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approachMichele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
Seminars in Oncology|September 20, 2017
In replyMichele Boisdron-Celle, Olivier Capitain, Roger Faroux, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
Pageof 7